SenesTech (SNES) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$2.4M

Revenue (quarter)

$770,000.00

Revenue growth (year over year)

+23.20%

Gross profit (trailing twelve months)

$1.6M

Gross margin

66.18%

Net income (trailing twelve months)

−$7.0M

Net income (quarter)

−$1.8M

Net income growth (year over year)

−13.37%

Net margin

−294.73%

Return on equity

−107.41%

EPS (trailing twelve months)

−$0.61

Book value per share

$1.14

P/E (trailing twelve months)

—

Price to book

0.56

Debt to assets

35.76%

Payout ratio

—

Dividend yield

—

Company profile

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

• Is SenesTech (SNES) profitable?

  No. SenesTech reported a net loss of $7.0M over the trailing twelve months.

• How much revenue does SenesTech (SNES) make?

  SenesTech generated $2.4M in revenue over the trailing twelve months, up 23.20% year over year.

• How do I buy stock in SenesTech (SNES)?

  SNES trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.